Ovarian Cancer Clinical Trial Patient Recruitment

Ovarian cancer clinical trial recruitment for BRCA-mutant, platinum-sensitive, and platinum-resistant studies.

Who qualifies: Women with epithelial ovarian cancer, including BRCA1/2 mutation carriers and platinum-sensitive/resistant patients.

Recruitment challenges: BRCA testing requirements and prior platinum therapy eligibility criteria.

Our approach: Gynecologic oncology referral networks and ovarian cancer patient advocacy partnerships.